About Biopharma's Ridiculously Bad DayManufacturing issues, unexpected regulatory holdups, and other issues abound.
A $43 Billion Biotech Now Has a Female CEOReshma Kewalramani is taking the reins at Vertex Pharmaceuticals from industry veteran Jeff Leiden.
Moderna Had the Biggest Biotech IPO Ever. Here's What That Says About the Industry's FutureNasdaq's health care listings chief discusses the future of biotech IPOs after Moderna's historic feat.
Controversial Startup Moderna Just Filed for the Biggest Biotech IPO EverThe unicorn is seeking to raise a staggering $500 million, despite having no products on the market.
Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPOThe blockbuster public offering pegs Allogene's market value at more than $2 billion.
China’s Biotech Boom Will Be a Wild RideInvestors will need to hold their nerve.
This Biotech Just Had a $903 Million IPO—And It's DisappointedCancer drug maker BeiGene was looking to score $1 billion in its secondary listing in Hong Kong.
Skip to Content
